Dan Brennan
Stock Analyst at TD Cowen
(3.59)
# 827
Out of 5,245 analysts
137
Total ratings
45.19%
Success rate
7.74%
Average return
Main Sectors:
Stocks Rated by Dan Brennan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDXH MDxHealth | Maintains: Buy | $7 → $1.5 | $0.80 | +87.50% | 3 | May 14, 2026 | |
| ALMR Alamar Biosciences | Initiates: Buy | $30 | $20.06 | +49.55% | 1 | May 12, 2026 | |
| QGEN Qiagen | Maintains: Hold | $46 → $40 | $35.17 | +13.73% | 1 | May 7, 2026 | |
| QTRX Quanterix | Maintains: Hold | $7 → $4 | $2.69 | +48.70% | 1 | May 7, 2026 | |
| WAT Waters | Maintains: Hold | $345 → $385 | $342.37 | +12.45% | 5 | May 6, 2026 | |
| RVTY Revvity | Maintains: Buy | $115 → $120 | $96.95 | +23.78% | 5 | May 6, 2026 | |
| GRAL GRAIL | Maintains: Buy | $65 → $69 | $67.19 | +2.69% | 1 | May 6, 2026 | |
| ADPT Adaptive Biotechnologies | Maintains: Buy | $19 → $21 | $13.88 | +51.30% | 2 | May 6, 2026 | |
| TEM Tempus AI | Maintains: Buy | $65 → $68 | $46.18 | +47.25% | 3 | May 6, 2026 | |
| NEO NeoGenomics | Maintains: Buy | $13 → $14 | $9.23 | +51.68% | 8 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $157 → $147 | $114.96 | +27.87% | 15 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $10 | $4.26 | +134.74% | 1 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $130 → $135 | $118.95 | +13.49% | 4 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $53 → $43 | $45.69 | -5.89% | 4 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $18 → $19 | $23.68 | -19.76% | 6 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $696 → $683 | $448.28 | +52.36% | 15 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $115 → $140 | $144.41 | -3.05% | 14 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $260 → $270 | $172.00 | +56.98% | 7 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $14 → $12 | $8.12 | +47.78% | 4 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $8 → $9 | $3.81 | +136.22% | 2 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $15.55 | +105.79% | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $110 | $47.31 | +132.51% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $2.5 | $4.40 | -43.18% | 4 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $155 → $175 | $203.19 | -13.87% | 4 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $250 | $160.30 | +55.96% | 5 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $51 | $48.35 | +5.48% | 2 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $56 | $14.93 | +275.08% | 1 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $545 → $546 | $127.18 | +329.31% | 4 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $13 → $15 | $1.22 | +1,129.51% | 1 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $207 → $232 | $116.78 | +98.66% | 6 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $770 → $880 | $1,103.09 | -20.22% | 3 | Oct 7, 2020 |
MDxHealth
May 14, 2026
Maintains: Buy
Price Target: $7 → $1.5
Current: $0.80
Upside: +87.50%
Alamar Biosciences
May 12, 2026
Initiates: Buy
Price Target: $30
Current: $20.06
Upside: +49.55%
Qiagen
May 7, 2026
Maintains: Hold
Price Target: $46 → $40
Current: $35.17
Upside: +13.73%
Quanterix
May 7, 2026
Maintains: Hold
Price Target: $7 → $4
Current: $2.69
Upside: +48.70%
Waters
May 6, 2026
Maintains: Hold
Price Target: $345 → $385
Current: $342.37
Upside: +12.45%
Revvity
May 6, 2026
Maintains: Buy
Price Target: $115 → $120
Current: $96.95
Upside: +23.78%
GRAIL
May 6, 2026
Maintains: Buy
Price Target: $65 → $69
Current: $67.19
Upside: +2.69%
Adaptive Biotechnologies
May 6, 2026
Maintains: Buy
Price Target: $19 → $21
Current: $13.88
Upside: +51.30%
Tempus AI
May 6, 2026
Maintains: Buy
Price Target: $65 → $68
Current: $46.18
Upside: +47.25%
NeoGenomics
Apr 29, 2026
Maintains: Buy
Price Target: $13 → $14
Current: $9.23
Upside: +51.68%
Apr 13, 2026
Maintains: Buy
Price Target: $157 → $147
Current: $114.96
Upside: +27.87%
Feb 24, 2026
Maintains: Buy
Price Target: $13 → $10
Current: $4.26
Upside: +134.74%
Feb 20, 2026
Maintains: Buy
Price Target: $130 → $135
Current: $118.95
Upside: +13.49%
Feb 13, 2026
Maintains: Hold
Price Target: $53 → $43
Current: $45.69
Upside: -5.89%
Feb 13, 2026
Maintains: Hold
Price Target: $18 → $19
Current: $23.68
Upside: -19.76%
Jan 30, 2026
Maintains: Buy
Price Target: $696 → $683
Current: $448.28
Upside: +52.36%
Jan 7, 2026
Maintains: Hold
Price Target: $115 → $140
Current: $144.41
Upside: -3.05%
Jan 7, 2026
Maintains: Buy
Price Target: $260 → $270
Current: $172.00
Upside: +56.98%
Jan 7, 2026
Maintains: Hold
Price Target: $14 → $12
Current: $8.12
Upside: +47.78%
Nov 4, 2025
Maintains: Hold
Price Target: $8 → $9
Current: $3.81
Upside: +136.22%
Jul 14, 2025
Initiates: Buy
Price Target: $32
Current: $15.55
Upside: +105.79%
May 1, 2025
Maintains: Buy
Price Target: $135 → $110
Current: $47.31
Upside: +132.51%
Mar 21, 2025
Maintains: Neutral
Price Target: $8 → $2.5
Current: $4.40
Upside: -43.18%
Nov 13, 2024
Maintains: Buy
Price Target: $155 → $175
Current: $203.19
Upside: -13.87%
Nov 7, 2024
Maintains: Buy
Price Target: $240 → $250
Current: $160.30
Upside: +55.96%
Jul 23, 2024
Maintains: Buy
Price Target: $48 → $51
Current: $48.35
Upside: +5.48%
May 13, 2024
Initiates: Buy
Price Target: $56
Current: $14.93
Upside: +275.08%
Dec 8, 2023
Maintains: Outperform
Price Target: $545 → $546
Current: $127.18
Upside: +329.31%
Mar 31, 2023
Upgrades: Outperform
Price Target: $13 → $15
Current: $1.22
Upside: +1,129.51%
Mar 1, 2021
Upgrades: Buy
Price Target: $207 → $232
Current: $116.78
Upside: +98.66%
Oct 7, 2020
Downgrades: Sell
Price Target: $770 → $880
Current: $1,103.09
Upside: -20.22%